Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Julphar
Chubb
US Department of Justice
Teva
Johnson and Johnson
Argus Health
Fuji
Fish and Richardson
Mallinckrodt

Generated: October 18, 2017

DrugPatentWatch Database Preview

Hydroxyzine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydroxyzine hydrochloride and what is the scope of hydroxyzine hydrochloride freedom to operate?

Hydroxyzine hydrochloride
is the generic ingredient in five branded drugs marketed by Vintage, Eci Pharms Llc, Elite Labs Inc, Hetero Labs Ltd Iii, Pharmafair, Luitpold, Amneal Pharm, Mutual Pharm, Solopak, Hi Tech Pharma, Ivax Pharms, Pfizer, Invagen Pharms, Organon Usa Inc, Hospira, Halsey, Pliva, Kv Pharm, Bayshore Pharms Llc, Purepac Pharm, Nuvo Pharm Inc, Usl Pharma, Watson Labs, Fresenius Kabi Usa, Quantum Pharmics, Northstar Hlthcare, Sandoz, Baxter Hlthcare, Wyeth Ayerst, Able, Sun Pharm Inds, Actavis Elizabeth, Aurolife Pharma Llc, Altana, Silarx Pharms Inc, Prinston Inc, Mylan, Heritage Pharma, Sti Pharma Llc, Roerig, Alpharma Us Pharms, Kvk Tech, Vintage Pharms, Smith And Nephew, Wockhardt, Superpharm, and Sun Pharm Inds Inc, and is included in one hundred and eight NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for hydroxyzine hydrochloride. Fifty-three suppliers are listed for this compound.

Summary for Generic Name: hydroxyzine hydrochloride

US Patents:0
Tradenames:5
Applicants:47
NDAs:108
Drug Master File Entries: see list19
Suppliers / Packagers: see list53
Bulk Api Vendors: see list103
Clinical Trials: see list2,302
Patent Applications: see list7,095
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:hydroxyzine hydrochloride at DailyMed

Pharmacology for Ingredient: hydroxyzine hydrochloride

Drug ClassAntihistamine
Mechanism of ActionHistamine Receptor Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
ATARAX
hydroxyzine hydrochloride
TABLET;ORAL010392-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL086829-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
ATARAX
hydroxyzine hydrochloride
TABLET;ORAL010392-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pliva
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL088619-001Jan 10, 1986ABRXNoYes► Subscribe► Subscribe► Subscribe
Watson Labs
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL086836-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd Iii
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL040805-001May 29, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Elite Labs Inc
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL040604-001Dec 28, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurolife Pharma Llc
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL087871-002Dec 20, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL088350-001Sep 15, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL087246-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
US Department of Justice
Farmers Insurance
Baxter
Chubb
Accenture
Boehringer Ingelheim
Cipla
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot